Investment Research Partners LLC acquired a new position in Centene Corporation (NYSE:CNC – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 8,039 shares of the company’s stock, valued at approximately $331,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in CNC. Prime Capital Investment Advisors LLC grew its holdings in Centene by 5.7% during the 4th quarter. Prime Capital Investment Advisors LLC now owns 5,975 shares of the company’s stock worth $246,000 after acquiring an additional 324 shares in the last quarter. Burney Co. grew its holdings in Centene by 3.8% during the 4th quarter. Burney Co. now owns 9,053 shares of the company’s stock worth $373,000 after acquiring an additional 331 shares in the last quarter. Sapient Capital LLC grew its holdings in Centene by 4.0% during the 4th quarter. Sapient Capital LLC now owns 9,442 shares of the company’s stock worth $389,000 after acquiring an additional 359 shares in the last quarter. Snowden Capital Advisors LLC grew its holdings in Centene by 8.0% during the 2nd quarter. Snowden Capital Advisors LLC now owns 5,073 shares of the company’s stock worth $275,000 after acquiring an additional 374 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB grew its holdings in Centene by 15.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 2,785 shares of the company’s stock worth $115,000 after acquiring an additional 379 shares in the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.
Analysts Set New Price Targets
CNC has been the subject of several research analyst reports. Truist Financial upped their target price on shares of Centene from $58.00 to $71.00 and gave the company a “buy” rating in a report on Monday, June 1st. Morgan Stanley upped their price target on shares of Centene from $50.00 to $57.00 and gave the company an “equal weight” rating in a research report on Thursday, June 4th. UBS Group reiterated a “neutral” rating and issued a $61.00 price target (up from $55.00) on shares of Centene in a research report on Friday, May 22nd. Weiss Ratings reiterated a “sell (d)” rating on shares of Centene in a research report on Monday, April 20th. Finally, Sanford C. Bernstein upped their price target on shares of Centene from $48.00 to $68.00 and gave the company an “outperform” rating in a research report on Tuesday, May 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Centene presently has an average rating of “Hold” and a consensus price target of $60.24.
Centene Stock Performance
Shares of CNC opened at $63.53 on Friday. The company has a 50-day simple moving average of $50.81 and a 200-day simple moving average of $44.17. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $31.37 billion, a PE ratio of -4.83, a P/E/G ratio of 0.51 and a beta of 1.09. Centene Corporation has a 52-week low of $25.08 and a 52-week high of $66.55.
Centene (NYSE:CNC – Get Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The company reported $3.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.23 by $1.14. The business had revenue of $49.94 billion during the quarter, compared to the consensus estimate of $47.53 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the firm posted $2.90 EPS. Equities research analysts predict that Centene Corporation will post 3.45 earnings per share for the current fiscal year.
About Centene
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Further Reading
- Five stocks we like better than Centene
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
